Is Encompass Health Corporation (EHC) a Buy, Sell, or Hold?
NYSE : EHC
Encompass Health Corporation — Analyst Ratings
$114.89 USD
$2 (1.77%)
- Volume
- 160.69K
- Average Volume
- 1.02M
- Market Capitalization
- $11.4B
- P/E Ratio
- 18.90
- Dividend Yield
- 0.66%
- Price Target
- $146.00
- Year High
- $127.99
- Year Low
- $92.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.12
- Current Ratio
- $1.17
Analyst Consensus Summary
Consensus Rating
Neutral
26 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-21.3%
vs Current Price
Price Target
$146.00
Average TargetPrice Target Range
Lowest Target
$140.00
-17.9% DOWNSIDE
Average Target
$146.00
Median Estimate
Highest Target
$152.00
-24.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 26
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 20 | 4 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Leerink Partners | Whit Mayo | $152 | $104.45 | 2026-05-22 06:20 AM | 45.5% |
| Barclays | Andrew Mok | $150 | $125.63 | 2025-10-30 06:21 AM | 19.4% |
| Truist Financial | David MacDonald | $140 | $119.295 | 2025-08-14 07:04 AM | 17.4% |
| RBC Capital | Ben Hendrix | $105 | $96.75 | 2024-09-26 04:09 AM | 8.5% |
| UBS | AJ Rice | $110 | $95.26 | 2024-09-25 03:39 AM | 15.5% |
| RBC Capital | Frank Morgan | $95 | $85.86 | 2024-05-22 02:16 AM | 10.6% |